A closer look to the new frontier of artificial intelligence in the percutaneous treatment of primary lesions of the liver
- 18 May 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Medical Oncology
- Vol. 37 (6), 1-7
- https://doi.org/10.1007/s12032-020-01380-y
Abstract
The purpose of thermal ablation is induction of tumor death by means of localized hyperthermia resulting in irreversible cellular damage. Ablative therapies are well-recognized treatment modalities for HCC lesions and are considered standard of care for HCC nodules < 3 cm in diameter in patients not suitable for surgery. Effective lesion treatment rely on complete target volume ablation. Technical limitations are represented by large (> 3 cm) or multicentric nodules as well as complex nodule location and poor lesion conspicuity. Artificial Intelligence (AI) is a general term referred to computational algorithms that can analyze data and perform complex tasks otherwise prerogative of Human Intelligence. AI has a variety of application in percutaneous ablation procedures such as Navigational software, Fusion Imaging, and robot-assisted ablation tools. Those instruments represent relative innovations in the field of Interventional Oncology and promising strategies to overcome actual limitations of ablative therapy in order to increase feasibility and technical results. This work aims to review the principal application of Artificial Intelligence in the percutaneous ablation of primary lesions of the liver with special focus on how AI can impact in the treatment of HCC especially on potential advantages on the drawbacks of the conventional technique.Keywords
This publication has 45 references indexed in Scilit:
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinomaJournal of Hepatology, 2012
- Initial experience with percutaneous biopsies of bone lesions using XperGuide cone-beam CT (CBCT): technical noteLa radiologia medica, 2012
- Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature ReviewInternational Journal of Hepatology, 2011
- A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan CriteriaAnnals of Surgery, 2010
- The Minimal Ablative Margin of Radiofrequency Ablation of Hepatocellular Carcinoma (> 2 and < 5 cm) Needed to Prevent Local Tumor Progression: 3D Quantitative Assessment Using CT Image FusionAmerican Journal of Roentgenology, 2010
- Targeted Sonography for Small Hepatocellular Carcinoma Discovered by CT or MRI: Factors Affecting Sonographic DetectionAmerican Journal of Roentgenology, 2010
- Targeting Liver Lesions for Radiofrequency AblationInvestigative Radiology, 2008
- Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation TherapyOncology, 2007
- Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center deviceSurgical Endoscopy, 2006
- Management of hepatocellular carcinomaHepatology, 2005